{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:40:32Z","timestamp":1777977632368,"version":"3.51.4"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Portuguese FCT R&D","award":["GHTM-UID\/04413\/2020"],"award-info":[{"award-number":["GHTM-UID\/04413\/2020"]}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["RegNet2015-1049"],"award-info":[{"award-number":["RegNet2015-1049"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Research Council","award":["AdG-2011-294428"],"award-info":[{"award-number":["AdG-2011-294428"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Delayed <jats:italic>Plasmodium falciparum<\/jats:italic> parasite clearance has been associated with Single Nucleotide Polymorphisms (SNPs) in the kelch protein propeller domain (coded by <jats:italic>pfk13<\/jats:italic> gene). SNPs in the <jats:italic>Plasmodium falciparum<\/jats:italic> multidrug resistance gene 1 (<jats:italic>pfmdr1)<\/jats:italic> are associated with multi-drug resistance including the combination artemether-lumefantrine. To our knowledge, this is the first work providing information on the prevalence of k13-propeller and <jats:italic>pfmdr1<\/jats:italic> mutations from S\u00e9dhiou, a region in the south of Senegal.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>147 dried blood spots on filter papers were collected from symptomatic patients attending a hospital located in Bounkiling City, S\u00e9dhiou Region, Southern Senegal. All samples were collected between 2015\u20132017 during the malaria transmission season. Specific regions of the gene <jats:italic>pfk13<\/jats:italic> and <jats:italic>pfmdr1<\/jats:italic> were analyzed using PCR amplification and Sanger sequencing.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The majority of parasites (92.9%) harboured the <jats:italic>pfk13<\/jats:italic> wild type sequence and 6 samples harboured synonymous changes. Regarding <jats:italic>pfmdr1<\/jats:italic>, wild-type alleles represented the majority except at codon 184. Overall, prevalence of 86Y was 11.9%, 184F was 56.3% and 1246Y was 1.5%. The mutant allele 184F decreased from 73.7% in 2015 to 40.7% in 2017. The prevalence of haplotype NFD decreased from 71.4% in 2015 to 20.8% in 2017.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This study provides the first description of <jats:italic>pfk13<\/jats:italic> and <jats:italic>pfmdr1<\/jats:italic> genes variations in Bounkiling, a city in the S\u00e9dhiou Region of Senegal, contributing to closing the gap of information on anti-malaria drug resistance molecular markers in southern Senegal.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0249357","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T17:37:13Z","timestamp":1616780233000},"page":"e0249357","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of pfk13 and pfmdr1 polymorphisms in Bounkiling, Southern Senegal"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7009-8408","authenticated-orcid":true,"given":"Ambroise","family":"Ahouidi","sequence":"first","affiliation":[]},{"given":"Rafael","family":"Oliveira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7251-5538","authenticated-orcid":true,"given":"Lis","family":"Lobo","sequence":"additional","affiliation":[]},{"given":"Cyrille","family":"Diedhiou","sequence":"additional","affiliation":[]},{"given":"Souleymane","family":"Mboup","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0313-0778","authenticated-orcid":true,"given":"Fatima","family":"Nogueira","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"pone.0249357.ref001","volume-title":"World Malaria Report 2019","author":"WHO","year":"2019"},{"key":"pone.0249357.ref002","first-page":"1","article-title":"Bulletin Epidemiologique Annuel 2017 du Paludisme au Senegal.","author":"Programme National de Lutte Contre le Paludisme","year":"2018","journal-title":"Ministere de la Sante."},{"key":"pone.0249357.ref003","article-title":"Scaling up malaria intervention \u201cpackages\u201d in Senegal: Using cost effectiveness data for improving allocative efficiency and programmatic decision-making.","author":"S Faye","year":"2018","journal-title":"Malar J."},{"key":"pone.0249357.ref004","unstructured":"Programme National de Lutte Contre le Paludisme. Progress & Impact Series: Focus on Senegal. Roll Back Malaria. 2010. p. 1\u201354."},{"key":"pone.0249357.ref005","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","author":"AM Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"pone.0249357.ref006","article-title":"Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia","author":"S Takala-Harrison","year":"2015","journal-title":"J Infect Dis"},{"issue":"5","key":"pone.0249357.ref007","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","article-title":"The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study","volume":"17","author":"M Imwong","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"pone.0249357.ref008","article-title":"Therapeutic failure after regimen with artemether-lumefantrine combination therapy: A report of three cases in Benin city, Nigeria.","author":"O Ebohon","year":"2019","journal-title":"Rev Soc Bras Med Trop."},{"key":"pone.0249357.ref009","article-title":"Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam","author":"N Van Hong","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"pone.0249357.ref010","article-title":"Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data.","author":"P Dahal","year":"2015","journal-title":"BMC Med."},{"issue":"1","key":"pone.0249357.ref011","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.1211205110","article-title":"Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia","volume":"110","author":"S Takala-Harrison","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"pone.0249357.ref012","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","author":"F Ariey","year":"2014","journal-title":"Nature"},{"key":"pone.0249357.ref013","unstructured":"WHO. Artemisinin resistance and artemisinin-based combination therapy efficacy: status report. [Internet]. 2018. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/274362."},{"key":"pone.0249357.ref014","article-title":"Molecular epidemiology of malaria in Cameroon and C\u00f4te d\u2019Ivoire. XXXI. Kelch 13 propeller sequences in plasmodium falciparum isolates before and after implementation of artemisinin-based combination therapy","author":"JA Djaman","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"pone.0249357.ref015","article-title":"Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012\u20132013.","author":"AM Dorkenoo","year":"2016","journal-title":"Malar J."},{"key":"pone.0249357.ref016","article-title":"K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: A systematic review of prevalence and risk factors.","author":"M Ocan","year":"2019","journal-title":"Malaria Journal"},{"issue":"3","key":"pone.0249357.ref017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02116-16","article-title":"The molecular epidemiology of Pf k13 mutations in Senegal using targeted amplicon deep sequencing","volume":"61","author":"E Talundzic","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0249357.ref018","article-title":"Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.","author":"A Boussaroque","year":"2016","journal-title":"Malar J."},{"key":"pone.0249357.ref019","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00759-17","article-title":"Sustained ex vivo susceptibility of Plasmodium falciparum to artemisinin derivatives but increasing tolerance to artemisinin combination therapy partner quinolines in The Gambia","author":"A Amambua-Ngwa","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0249357.ref020","article-title":"West Africa international centers of excellence for malaria research: Drug resistance patterns to artemether-lumefantrine in Senegal, Mali, and the Gambia","author":"B Dieye","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"pone.0249357.ref021","article-title":"Proof of concept: Used malaria rapid diagnostic tests applied for parallel sequencing for surveillance of molecular markers of anti-malarial resistance in Bissau, Guinea-Bissau during 2014\u20132017.","author":"S Nag","year":"2019","journal-title":"Malar J."},{"key":"pone.0249357.ref022","article-title":"Polymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, Mali","author":"A Ouattara","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pone.0249357.ref023","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1083\/jcb.113.5.1033","article-title":"A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole","volume":"113","author":"AF Cowman","year":"1991","journal-title":"J Cell Biol"},{"key":"pone.0249357.ref024","article-title":"Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria","author":"GS Humphreys","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0249357.ref025","article-title":"Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic","author":"C Dokomajilar","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0249357.ref026","article-title":"In vivo selection of plasmodium falciparum pfcrt and pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso","author":"V Baraka","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0249357.ref027","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","author":"RN Price","year":"2004","journal-title":"Lancet"},{"key":"pone.0249357.ref028","article-title":"Role of Pfmdr1 in In Vitro Plasmodium falciparum Susceptibility to Chloroquine, Quinine, Monodesethylamodiaquine, Mefloquine, Lumefantrine, and Dihydroartemisinin","author":"N Wurtz","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0249357.ref029","article-title":"Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether-lumefantrine treatment in Mali.","author":"S Dama","year":"2017","journal-title":"Malar J."},{"key":"pone.0249357.ref030","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies.","author":"MI Veiga","year":"2016","journal-title":"Nat Commun."},{"key":"pone.0249357.ref031","article-title":"Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal","author":"A Mbaye","year":"2016","journal-title":"Malar J"},{"key":"pone.0249357.ref032","article-title":"Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal.","author":"MA Diallo","year":"2020","journal-title":"Sci Rep."},{"key":"pone.0249357.ref033","article-title":"Cytokine response during non-cerebral and cerebral malaria: Evidence of a failure to control inflammation as a cause of death in African adults.","author":"Y Dieye","year":"2016","journal-title":"PeerJ"},{"key":"pone.0249357.ref034","article-title":"Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015.","author":"S Diawara","year":"2017","journal-title":"Malar J."},{"key":"pone.0249357.ref035","article-title":"Modulation of in vitro antimalarial responses by polymorphisms in Plasmodium falciparum ABC transporters (pfmdr1 and pfmdr5).","author":"M Gendrot","year":"2019","journal-title":"Acta Trop"},{"key":"pone.0249357.ref036","article-title":"Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012\u20132013.","author":"M Torrentino-Madamet","year":"2014","journal-title":"Malaria Journal."},{"key":"pone.0249357.ref037","article-title":"Emergence of mutations in the K13 propeller gene of Plasmodium falciparum isolates from Dakar, Senegal, in 2013\u20132014","author":"A Boussaroque","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0249357.ref038","article-title":"Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal.","author":"M Madamet","year":"2017","journal-title":"Int J Antimicrob Agents."},{"issue":"1","key":"pone.0249357.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-0589-3","article-title":"Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013\u20132014 malaria season.","volume":"14","author":"B Fall","year":"2015","journal-title":"Malar J"},{"issue":"25","key":"pone.0249357.ref040","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","article-title":"A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms","volume":"374","author":"D M\u00e9nard","year":"2016","journal-title":"N Engl J Med"},{"key":"pone.0249357.ref041","article-title":"Polymorphism in dhfr\/dhps genes, parasite density and ex vivo response to pyrimethamine in plasmodium falciparum malaria parasites in thies, senegal","author":"D Ndiaye","year":"2013","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"pone.0249357.ref042","article-title":"Short report: Rapid DNA extraction from archive blood spots on filter paper for genotyping of Plasmodium falciparum","author":"S Bereczky","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"pone.0249357.ref043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119215","article-title":"Polymorphisms in Plasmodium falciparum K13-propeller in angola and mozambique after the introduction of the ACTs.","volume":"10","author":"C Escobar","year":"2015","journal-title":"PLoS One."},{"key":"pone.0249357.ref044","article-title":"A worldwide map of Plasmodium falciparum K13-propeller polymorphisms","author":"D M\u00e9nard","year":"2016","journal-title":"N Engl J Med"},{"key":"pone.0249357.ref045","unstructured":"WWARN. Plasmodium falciparum and artemisinin combination therapies. 2020."},{"key":"pone.0249357.ref046","article-title":"Changing molecular markers of antimalarial drug sensitivity across Uganda","author":"V Asua","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0249357.ref047","article-title":"Plasmodium falciparum Kelch Propeller Polymorphisms in Clinical Isolates from Ghana from 2007 to 2016","author":"SA Matrevi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0249357.ref048","article-title":"K13-propeller polymorphisms in plasmodium falciparum parasites from sub-saharan Africa","author":"E Kamau","year":"2015","journal-title":"J Infect Dis"},{"key":"pone.0249357.ref049","article-title":"The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: A meta-analysis of individual patient data.","author":"MT Bretscher","year":"2020","journal-title":"BMC Med."},{"key":"pone.0249357.ref050","article-title":"Emerging implications of policies on malaria treatment: Genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether\u2013lumefantrine and artesunate\u2013amodiaquine in Africa.","author":"LC Okell","year":"2018","journal-title":"BMJ Glob Heal"},{"key":"pone.0249357.ref051","article-title":"Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal.","author":"D Van Tyne","year":"2013","journal-title":"Malar J."},{"key":"pone.0249357.ref052","article-title":"Short report: A non-radioactive DAPI-based high-throughput in vitro assay to assess Plasmodium falciparum responsiveness to antimalarials\u2014Increased sensitivity of P. falciparum to chloroquine in senegal","author":"D Ndiaye","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"pone.0249357.ref053","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00436-012-2994-7","article-title":"Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal.","volume":"111","author":"O Ly","year":"2012","journal-title":"Parasitol Res"},{"key":"pone.0249357.ref054","article-title":"Changes in malaria parasite drug resistance in an endemic population over a 25-year period with resulting genomic evidence of selection","author":"DC Nwakanma","year":"2014","journal-title":"J Infect Dis"},{"key":"pone.0249357.ref055","article-title":"Surveillance of Antimalarial Resistance Pfcrt, Pfmdr1, and Pfkelch13 Polymorphisms in African Plasmodium falciparum imported to Shandong Province, China.","author":"C Xu","year":"2018","journal-title":"Sci Rep."},{"key":"pone.0249357.ref056","article-title":"Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections.","author":"DR Pillai","year":"2012","journal-title":"Malar J."},{"key":"pone.0249357.ref057","article-title":"Artemether-lumefantrine and dihydroartemisinin-piperaquine exert inverse selective pressure on plasmodium falciparum drug sensitivity-associated haplotypes in Uganda.","author":"AR Taylor","year":"2017","journal-title":"Open Forum Infect Dis."},{"key":"pone.0249357.ref058","article-title":"Selective sweeps and genetic lineages of Plasmodium falciparum multi-drug resistance (pfmdr1) gene in Kenya.","author":"P Muiruri","year":"2018","journal-title":"Malar J"},{"key":"pone.0249357.ref059","article-title":"Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.","author":"RA Kavishe","year":"2014","journal-title":"Malar J"},{"key":"pone.0249357.ref060","article-title":"Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in nigerian children with uncomplicated falciparum malaria","author":"CT Happi","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0249357.ref061","article-title":"Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms","author":"M Malmberg","year":"2013","journal-title":"J Infect Dis"},{"key":"pone.0249357.ref062","article-title":"Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda","author":"FN Baliraine","year":"2011","journal-title":"J Infect Dis"},{"key":"pone.0249357.ref063","article-title":"High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology.","author":"S Nag","year":"2017","journal-title":"Sci Rep."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0249357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T17:38:11Z","timestamp":1616780291000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0249357"}},"subtitle":[],"editor":[{"given":"Luzia Helena","family":"Carvalho","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0249357","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]}}}